Publicacións (52) Publicacións de Adrián Sousa Dominguez

2024

  1. A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 8, pp. 1794-1800

  2. Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study

    Clinical Microbiology and Infection, Vol. 30, Núm. 8, pp. 1035-1041

  3. Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study

    Annals of Clinical Microbiology and Antimicrobials, Vol. 23, Núm. 1

  4. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

  5. Mortality impact of further delays in active targeted antibiotic therapy in bacteraemic patients that did not receive initial active empiric treatment: Results from the prospective, multicentre cohort PROBAC

    International Journal of Infectious Diseases, Vol. 145

  6. Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study

    The Lancet Microbe, Vol. 5, Núm. 4, pp. e390-e399

2023

  1. A Confounder in the Study of a Patient With Infective Endocarditis

    JACC: Case Reports, Vol. 28

  2. Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales

    Annals of Clinical Microbiology and Antimicrobials, Vol. 22, Núm. 1

  3. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  4. Impact of Methylprednisolone Pulse on the Mortality of Patients With Acute Respiratory Distress Syndrome Secondary to COVID-19

    Infectious Diseases in Clinical Practice, Vol. 31, Núm. 6

  5. Mycotic Aortic Aneurysm after Intravesical Bacillus Calmette-Guérin Instillation for Bladder Carcinoma

    Infectious Diseases in Clinical Practice

2022

  1. Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 9, pp. 1173-1182

  2. Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients

    Frontiers in Pharmacology, Vol. 13

  3. Gastrointestinal colonization by OXA-48-producing Enterobacterales: risk factors for persistent carriage

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 12, pp. 1399-1405

  4. Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 5, pp. 1452-1460

  5. Oral sequential therapy in the treatment of post-surgical epidural abscess and subdural empyema

    Infection, Vol. 50, Núm. 5, pp. 1385-1389

  6. Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project

    Microbiology spectrum, Vol. 10, Núm. 4, pp. e0005122

  7. Risk of cardiac device-related infection in patients with late-onset bloodstream infection. Analysis on a National Cohort

    Journal of Infection, Vol. 85, Núm. 2, pp. 123-129

  8. Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial)

    PLoS ONE, Vol. 17, Núm. 12 December

  9. Successful ceftazidime–avibactam therapy in a patient with multidrug-resistant Pseudomonas aeruginosa infective endocarditis

    Infection